Top 10 Medical Startup Investors in Mexico in May 2026

Portfolio highlights

• Clau — Clau is a leading real estate platform that simplifies buying, selling, and remodeling properties. It acts as a real estate superapp combining a property marketplace with CRM tools for brokers, mortgage brokerage services, renovation connections, and a data platform for market insights. It serves homebuyers, brokers, sellers, and investors seekingstreamlined property transactions and market data.
• R2 — R2 enables platforms to seamlessly offer financing to their merchants in Latin America. The company was founded in 2020, and currently operates in Mexico, Colombia, and Ecuador.
• Mendel — Optimiza tus gastos con Mendel: control eficiente, flujos automatizados, seguridad antifraude, integraciones y datos impulsados por IA.

Portfolio highlights

• Shots Podcast Network — Shots Studios is a podcast network servicing the top podcasts on YouTube. The audio versions of the podcasts can be found on Spotify and Apple along with clips on Instagram, Snapchat and TikTok.
• Voy al Doc — Voy al Doc is Mexico’s first online medical care scheduling service, which provides online search and booking options for patients free of charge.Their service meets the needs of both patients and medical practitioners. It helps patients find a doctor of a particular specialty in the most convenient location for them and allows them to book anappointment instantly online or by phone. It also helps doctors attract and retain new patients and support them managing their appointments and filling in last minute cancellations.Voy al Doc is backed by notable VC funds in Mexico (ALL VP and Angel Ventures) and is one of the few Mexican startups that has been backed by US funds (Nala Investments). Besides from that they have received funding twice from INADEM (government support for startups).Detailed traction graphs available upon request.
• Synadia Communications — Synadia | Secure, decentralized, secure global utility, powered by NATS for IoT, microservices and all digital systems.

Portfolio highlights

• Carryt — Carryt performs efficient last mile deliveries by empowering gig economy drivers with our route optimization technology and impact strategy.
• Syncfy — LATAM's leading financial API.
• Axify — On Axify we offer prepayment installment plans to acquire services, like a "tanda" of the digital age. The company is seeing huge potential and interest in different industries: travel, e-commerce, insurance, hospitals, health, and beauty centers. The company focuses on helping people who lack resources or even a credit card acquire aquality product without the predatory lending rates, which are very expensive and generate a huge burden on Mexican and LatAm families. That said we give prepayment plans to people and help them, by creating a pre-payment plan, acquire the products and services in a sustainable free-of-debt manner. We are seeing a tendency to avoid debt all over Mexico and we have already helped more than 7000 families acquire products or services without any kind of debt.

Portfolio highlights

• Chari — Chari is an e-commerce and fintech app for traditional retailers in French-Speaking Africa allowing them to order any consumer goods they sell and get delivered for free in less than 24 hours. Chari is also a financial services provider for these retailers, offering them microloans
• Ecomm-App — Ecomm-App is an online platform that helps online merchants to manage their inventory in real-time and invoice in seconds.
• Fellow Pay — The faster, easier and fairer way to get your invoices paid and speed up your payment cycle. For B2B SMEs with long payment cycles across all industries.

Portfolio highlights

• Blooms — Blooms provides trade finance and global payments solutions for LatAm produce exporters.
• Clip — Clip is changing card acceptance in Mexico, offering different models of portable card-reading hardware to accept all credit and debit cards as well as other solutions. More than a device to accept all cards, Clip is an ally focused on empowering Mexican businesses.
• Monato — Monato is a fintech that builds modular, scalable financial infrastructure that allows companies to integrate financial services in compliance with regulations.

Portfolio highlights

• Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
• Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
• Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.

Portfolio highlights

• StrongView — StrongView helps brands understand, engage, and deliver value to consumers. Recognized as a leading provider of email and cross-channel marketing solutions, StrongView is reinventing customer relationship marketing through customer context. Our contextual marketing solutions enable brands to recognize and act on consumers' fast-changingcircumstances before, during, and after each moment of engagement.Based in Redwood City, CA, and backed by leading investors, StrongView seeks to challenge traditional marketing approaches and enable customer context as a new foundation for delivering value.
• Voy al Doc — Voy al Doc is Mexico’s first online medical care scheduling service, which provides online search and booking options for patients free of charge.Their service meets the needs of both patients and medical practitioners. It helps patients find a doctor of a particular specialty in the most convenient location for them and allows them to book anappointment instantly online or by phone. It also helps doctors attract and retain new patients and support them managing their appointments and filling in last minute cancellations.Voy al Doc is backed by notable VC funds in Mexico (ALL VP and Angel Ventures) and is one of the few Mexican startups that has been backed by US funds (Nala Investments). Besides from that they have received funding twice from INADEM (government support for startups).Detailed traction graphs available upon request.
• Meru Networks — Meru Networks develops and markets wireless LAN infrastructure solutions that use virtualization to deliver pervasive, high-fidelity wireless service for business-critical voice, video and data applications. The company first introduced its award-winning virtual cell wireless architecture in 2003, and Meru products embody a complete departure fromtypical hub-based WLAN approaches, offering a wireless solution with levels of performance, reliability, security and cost-effectiveness previously found only in wired networking environments.

Portfolio highlights

• wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
• Bioherent — Photonic biosensors for drug allergy diagnosis
• Inspiration-Q — Quantum-inspired optimization for financial markets

Portfolio highlights

• Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
• Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
• Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Portfolio highlights

• Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.